Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Electronics And Telecommunication Research Institute currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio's prosecution is concentrated under 1 distinct examiner and 1 distinct art unit. This indicates a singular point of focus for the company's current patenting efforts in this specific technology sector. Such a centralized profile allows for a more efficient allocation of legal resources toward a specific objective.
CHARLES ALAN MARMOR II is the busiest examiner for the company, with 1 busiest examiner pending office action. This 1 action is the only pending office action currently recorded for the portfolio. The presence of 1 distinct examiner means that the company's short-term patent success is tied to the feedback from this specific individual. Practitioners can focus on the specific examination history of this 1 distinct art unit to anticipate potential hurdles. This streamlined prosecution environment minimizes the administrative complexity often found in larger, more diverse portfolios.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARMOR II, CHARLES ALAN | 1 | 12.6% | +26.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17584246 | METHOD AND SYSTEM FOR ESTIMATING ARTERIAL BLOOD BASED ON DEEP LEARNING | MARMOR II, CHARLES ALAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17584246 | METHOD AND SYSTEM FOR ESTIMATING ARTERIAL BLOOD BASED ON DEEP LEARNING | MARMOR II, CHARLES ALAN | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17584246 | METHOD AND SYSTEM FOR ESTIMATING ARTERIAL BLOOD BASED ON DEEP LEARNING | MARMOR II, CHARLES ALAN | 1685 | §103§112 | Non-Final OA | — | Pending | Jan 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialElectronics And Telecommunication Research Institute has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Charles Alan Marmor II has the most, with 1 of Electronics And Telecommunication Research Institute's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
